A composition for repelling ticks and its preparation method

By combining liposomes loaded with recombinant Mindin protein and total protein from tick salivary gland extract in the tick repellent composition with plant essential oils and DEET to form a semi-solid gel reservoir, the problem of single-function repellents and insecticides in existing technologies is solved. This achieves synergistic control of chemical repellency and immune pre-activation, improving tick protection and the host's active disease resistance.

CN123100616APending Publication Date: 2026-11-17XIAN MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611042127.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-07-14
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing repellents such as DEET only have a repellent effect and no contact killing function. Although pyrethroid insecticides have a contact killing effect, their repellent effect on ticks is limited. Single-function products cannot play a role at different stages of tick contact with the host, and long-term use leads to ticks developing drug resistance.

Method used

A composition for repelling and killing ticks is provided, comprising an immune-activating phase, a tick-repelling active phase, and a thermosensitive in-situ gel matrix. The composition is formed by loading recombinant Mindin protein and total protein from tick salivary gland extract onto liposomes, combined with plant essential oils and DEET, to achieve synergistic control through chemical repellency and immune pre-activation.

Benefits of technology

It significantly prolongs the repellency time, improves the tick protection effect, and achieves dual protection from external chemical blocking to in vivo immune clearance, avoiding the problem of incompatibility between hydrophilic and hydrophobic substances and enhancing the host's active disease resistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_3
    Figure SMS_3
  • Figure SMS_4
    Figure SMS_4
  • Figure SMS_5
    Figure SMS_5
Patent Text Reader

Abstract

This application discloses a tick-repelling composition and its preparation method, relating to the field of tick repellent composition technology. The composition comprises an immune-activating phase, a tick-repelling active phase, and a thermosensitive in-situ gel matrix; the immune-activating phase contains liposomes loaded with recombinant Mindin protein and total protein from tick salivary gland extract; the tick-repelling active phase contains plant essential oils and DEET; the two phases are dispersed together in the thermosensitive in-situ gel matrix, forming a semi-solid gel reservoir at body temperature. This application also discloses a method for preparing the composition. The composition of this application achieves tick control through a dual mechanism of chemical repellency and immune pre-activation, while simultaneously solving technical problems such as the compatibility of hydrophilic and hydrophobic active ingredients, transdermal delivery of large molecular proteins, and long-term storage stability.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to insect repellent compositions, and more particularly to a composition for repelling and killing ticks and its preparation method. Background Technology

[0002] Ticks belong to the phylum Arthropoda, class Arachnida, subclass Acari, and are commonly known as ticks. They are obligate blood-sucking ectoparasites with a life cycle consisting of four stages: egg, larva, nymph, and adult. Each stage requires blood to complete development. When a tick bites, it secretes an anesthetic toxin from its mouthparts, allowing the host to be continuously fed on without feeling pain. More seriously, ticks are important vectors for many pathogens. Worldwide, ticks are known to carry 83 types of viruses, 4 types of bacteria, 17 types of spirochetes, and 32 types of protozoa, transmitting various tick-borne diseases such as fever with thrombocytopenia syndrome (SFTS), Lyme disease, and Q fever, with a mortality rate as high as 30%.

[0003] Recombinant Mindin protein (encoded by the mouse spon 2 gene) is an extracellular matrix protein, also known as Spondin2, which can be used as a vaccine adjuvant. In previous studies, a technique was developed to use recombinant Mindin protein as an adjuvant in combination with recombinant Toxoplasma gondii antigens rBAG1, rSRS4, and rSRS9 to immunize BALB / c mice. This study found that Mindin could enhance antigen-specific humoral and cellular immune responses and improve the survival rate of mice after lethal challenge. This research has been published in *BMC Infectious Diseases* (The extracellular matrix protein mindin as a novel adjuvant elicits stronger immune responses for rBAG1, rSRS4 and rSRS9 antigens of Toxoplasma gondii in BALB / c mice. BMC Infectious Diseases, 2014, 14: 429.).

[0004] Currently, tick control mainly relies on the following technical methods:

[0005] Chemical repellents. The most commonly used repellent is one containing 20% ​​DEET, which is applied to the skin and clothing to prevent tick bites. DEET does not kill ticks by contact and is currently considered to be somewhat toxic; therefore, it is not recommended for use on children under 6 months of age and pregnant women.

[0006] Chemical insecticides. Pyrethroid insecticides (such as cypermethrin) are neurotoxic to insects, broad-spectrum, and safe for humans and animals. However, long-term use of chemical pesticides can lead to tick resistance, weakening their repellent and contact-killing effects.

[0007] Plant-derived repellents. Natural plant essential oils have repellent, antifeedant, growth-inhibiting, and direct-killing effects on insects, and can be used as safe and low-toxicity natural repellents. Plant-derived insecticides are characterized by high efficiency, low toxicity, no pollution, and low likelihood of pests developing resistance. However, the repellency time and contact killing effect of single plant essential oils are often inferior to those of chemically synthesized repellents.

[0008] Anti-tick vaccines. Existing anti-tick vaccines have certain limitations, and vaccine target identification and development still face many challenges.

[0009] The existing technology has the following technical problems: DEET repellents only have a repellent effect and no contact killing function. Pyrethroid insecticides, while having contact killing effects, have limited repellent efficacy against ticks. Single-function products cannot be effective at different stages of tick contact with the host. High concentrations of DEET (20%) have good repellent efficacy but pose a toxicity risk; reducing the concentration improves safety but decreases repellent efficacy. Existing repellent products only provide a chemical barrier; once a tick breaks through this barrier and successfully bites, the host still faces the risk of tick-borne pathogen infection. Long-term use of chemical pesticides has led to tick resistance. Summary of the Invention

[0010] This application provides a composition for repelling and killing ticks and a method for preparing the same, which solves the problems existing in the prior art.

[0011] This application provides a composition for repelling and killing ticks, comprising an immune-activating phase, a tick-repelling active phase, and a thermosensitive in-situ gel matrix; The immune activation phase comprises liposomes loaded with recombinant Mindin protein and total protein from tick salivary gland extract, the liposomes being composed of phospholipids, cholesterol, polyethylene glycol-modified distearate phosphatidylethanolamine and a penetration enhancer; The repellent active phase contains plant essential oils and DEET; The thermosensitive in-situ gel matrix contains poloxamer and cellulose-based polymers; The immune-activating phase and the exterminating active phase are dispersed together in the thermosensitive in situ gel matrix, and the composition undergoes a phase transition under body temperature to form a semi-solid gel reservoir.

[0012] Furthermore, by weight percentage, the composition comprises: Mindin recombinant protein 0.005%-0.02%; The total protein content of tick salivary gland extract was 0.001%-0.01%. Trehalose 1%-3%; Phospholipids 2%-5%; Cholesterol content is 0.3%-1.0%, and the weight ratio of phospholipids to cholesterol is 4:1-10:1; 1,2-Propanediol 5%-10%; Penetration enhancer 0.5%-2.0%; Polyethylene glycol-modified distearate phosphatidylethanolamine 0.1%-0.5%; Plant essential oils 0.5%-5%; DEET 0.5%-5%; Anhydrous ethanol 5%-10%; Polysorbate-80 0.5%-2%; Poloxamer 407 18%-25%; Poloxamer 188 2%-6%; Hydroxypropyl methylcellulose 0.3%-1.0%; The remainder is phosphate buffer.

[0013] Furthermore, the penetration enhancer is choline-lauric acid or choline-oleic acid.

[0014] Furthermore, the plant essential oil is any one or a combination of clove essential oil, walnut leaf essential oil, and thyme essential oil.

[0015] Furthermore, the liposome has an inner aqueous phase and an outer aqueous phase. The sodium chloride concentration of the inner aqueous phase is 0.85%-0.95%, and the osmotic pressure is 280-320 mOsmol / L. The sodium chloride concentration of the outer aqueous phase and the thermosensitive in-situ gel matrix is ​​0.15%-0.30%, and the osmotic pressure is 50-100 mOsmol / L. The osmotic pressure difference between the inner and outer aqueous phases is 180-270 mOsmol / L.

[0016] Furthermore, the tick salivary gland extract is derived from the salivary glands of semi-engorged female adult ticks of the Turantopteris turanosa.

[0017] Furthermore, the temperature-sensitive in-situ gel matrix gels at 33℃±1℃, and the gelation time at 37℃ does not exceed 45 seconds.

[0018] The method for using the above-mentioned tick-repelling composition includes the following steps: S1: The protein solution of tick salivary gland extract was mixed with trehalose and then freeze-dried to obtain tick salivary gland extract-trehalose freeze-dried powder; phospholipids, cholesterol and polyethylene glycol-modified distearate phosphatidylethanolamine were dissolved in an organic solvent, and the organic solvent was removed by rotary evaporation under reduced pressure to form a lipid membrane. S2: Dissolve the Mindin recombinant protein in phosphate buffer, add a penetration enhancer and 1,2-propanediol, and stir until completely dissolved to obtain a hydration solution; add the hydration solution to a container containing the lipid membrane and stir to hydrate and detach the lipid membrane completely to form a crude liposome suspension. S3: The crude liposome suspension is subjected to ultrasonic treatment and extrusion membrane to obtain liposomes; the tick salivary gland extract-trehalose lyophilized powder is reconstituted and added to the liposomes, so that the tick salivary gland extract protein is adsorbed on the surface of the liposomes or encapsulated in the aqueous phase of the liposomes; the unencapsulated free protein is removed by ultrafiltration centrifugation to obtain liposomes loaded with Mindin recombinant protein and total protein of tick salivary gland extract; S4: Poloxamer 407, poloxamer 188, and hydroxypropyl methylcellulose were added to pre-cooled purified water and swollen to obtain a thermosensitive in-situ gel matrix; DEET was dissolved in anhydrous ethanol, and plant essential oil and polysorbate-80 were added and stirred to obtain a repellent active phase stock solution; under low temperature conditions, the liposomes obtained in step S3 were added to the thermosensitive in-situ gel matrix and mixed, and then the repellent active phase stock solution was added, phosphate buffer was added, and the mixture was stirred and mixed to obtain the final product.

[0019] Furthermore, in step S3, the ultrafiltration centrifugation method uses an ultrafiltration membrane with a molecular weight cutoff of 100 kDa, a centrifugal force of 4000×g, a temperature of 4℃, a time of 20 min, and is repeated 3 times; the freeze-drying conditions are: pre-freezing at -80℃ for 12 h, cold trap temperature of -50℃, vacuum degree less than 10 Pa, and freeze-drying time of 48 h; the ultrasonic treatment conditions are: ultrasonic power of 150W, total ultrasonic time of 10 min, ultrasonic 2 s interval 3 s, ice-water bath protection throughout, and temperature controlled at 4-10℃; the extrusion membrane is extruded 5 times through a 0.45 μm polycarbonate membrane and 5 times through a 0.22 μm polycarbonate membrane, with an extrusion pressure of 1.0 MPa.

[0020] Furthermore, in step S3, a hypotonic phosphate buffer is used as the replacement medium for ultrafiltration centrifugation to replace the lipid in vitro aqueous phase with a hypotonic environment. The hypotonic phosphate buffer has a sodium chloride concentration of 0.15%-0.30% and a pH of 7.4.

[0021] One or more technical solutions provided in the embodiments of this application have at least the following technical effects or advantages: This application achieves synergistic control of chemical extermination and immune pre-activation by dispersing the immune-activating phase and the extermination-killing active phase together in a thermosensitive in situ gel matrix. This upgrades the tick protection mode from a single in vitro chemical blockade to a dual protection mechanism that combines in vitro extermination and in vivo immune clearance, fundamentally making up for the deficiency that simple extermination products cannot enhance the host's active disease resistance.

[0022] This application utilizes liposomes to encapsulate the hydrophilic Mindin protein in the inner aqueous phase, while simultaneously loading the hydrophobic antagonistic active ingredient into the liposome membrane and gel backbone. This avoids direct contact and conflict between the two, solves the technical problem of incompatibility between hydrophilic and hydrophobic substances, and ensures that the presence of high-concentration essential oils does not affect the structural integrity of the Mindin protein.

[0023] The liposome-gel composite matrix of this application changes the release pathway of the repellent active ingredient from direct volatilization to a three-stage release mode of distribution through liposome membrane, gel blockage, and then diffusion into the gas phase, which significantly prolongs the effective repellency time.

[0024] This application introduces an ionic liquid combined with a liposome delivery system, enabling the transdermal delivery of the Mindin macromolecular protein, which was originally unable to penetrate the skin alone, under topical conditions, providing a feasible route for non-injectable administration of protein-based immune adjuvants. Detailed Implementation

[0025] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains; the terminology used herein in the description of the invention is for the purpose of describing particular embodiments only and is not intended to limit the invention; the term "and / or" as used herein includes any and all combinations of one or more of the associated listed items.

[0026] Example 1: This example provides a composition for repelling ticks, consisting of an immune-activating phase (a liposome transdermal delivery system containing Mindin protein) and a tick-repelling active phase (plant essential oil + DEET) dispersed in a thermosensitive in-situ gel matrix. When administered, it is applied in liquid form to areas such as the base of the ears and tail of livestock. Under body temperature (37–39°C), a rapid phase transition occurs, forming a semi-solid gel reservoir, achieving sustained release of the tick-repelling components and local delivery of the immune adjuvant.

[0027] The immune activation phase, by weight percentage of the composition, specifically comprises: 0.005%–0.02% recombinant Mindin protein; 0.001%–0.01% total protein from tick salivary gland extract (SEG); 1%–3% trehalose; 2%–5% soybean lecithin; 0.3%–1.0% cholesterol (lecithin:cholesterol = 4:1–10:1); 5%–10% 1,2-propanediol; 0.5%–2.0% penetration enhancer (choline-lauric acid / choline-oleic acid); 0.1%–0.5% DSPE-PEG2000; and the balance being phosphate-buffered saline (PBS, pH 7.4). The tick salivary gland extract (SEG) was obtained from the semi-saturated female adult ticks of Rhipicephalus turanicus (3-5 days after biting the host, the tick was in a semi-saturated state) through dissection, gland extraction, freeze-thaw, homogenization, ultrasonic disruption, centrifugation, and concentration.

[0028] The repellent active phase, by weight percentage of the composition, specifically includes: 0.5%~5% of plant essential oils (any one or combination of clove oil, thyme oil, walnut leaf oil, and thyme oil); 0.5%~5% of DEET; 5%~10% of anhydrous ethanol; and 0.5%~2% of Tween-80.

[0029] The thermosensitive in-situ gel matrix, by weight percentage of the composition, specifically comprises: poloxamer 407 (P407) 18%~25%; poloxamer 188 (P188) 2%~6%; and hydroxypropyl methylcellulose (HPMC) 0.3%~1.0%. The preparation method of the above-mentioned tick-repellent composition is as follows: S1. Mix the SGE protein solution with trehalose in a ratio (SGE protein: trehalose = 1:15, mass ratio), and then... After pre-freezing at 80°C for 12 hours, it is transferred to a freeze dryer for freeze drying (cold trap temperature). SGE-trehalose freeze-dried powder was obtained by freezing at 50°C, vacuum degree <10 Pa, and freeze-drying time 48 h.

[0030] Weigh out 3.5g of soybean lecithin, 0.6g of cholesterol, and 0.3g of DSPE-PEG2000 by weight percentage, and dissolve them in an appropriate amount of chloroform-methanol (2:1, v / v) mixed solvent in a round-bottom flask (200 rpm, 25℃, 30 min). Then, slowly remove the organic solvent by rotary evaporation under reduced pressure in a 45℃ water bath (70 rpm, -0.08 MPa) until a uniform, transparent film forms on the flask wall; this is the lipid film. Continue vacuum drying for 12 h to completely remove residual solvent.

[0031] S2. Dissolve Mindin protein in PBS buffer (pH 7.4, 50 mL), add 1.2 g of choline-lauric acid and 8 g of 1,2-propanediol, and stir until completely dissolved (stirring speed 300 rpm, temperature 25℃, time 15 min) to obtain a hydration solution; add the hydration solution to a flask containing a lipid membrane, and hydrate and stir in a 45℃ water bath for 45 min (stirring speed 200 rpm) to completely hydrate and detach the lipid membrane, forming a milky white crude liposome suspension.

[0032] The amount of Mindin protein used was divided into three groups, which were 0.005%, 0.01%, and 0.02% by mass percentage.

[0033] S3. Perform ultrasonic treatment: ultrasonic power 150 W, total ultrasonic time 10 min (2 s per ultrasonic session, 3 s interval), ice water bath protection throughout, temperature controlled at 4~10℃; the ultrasonicated liposome suspension was extruded through a 0.45 μm polycarbonate membrane 5 times and a 0.22 μm polycarbonate membrane 5 times (extrusion pressure 1.0 MPa) to obtain Mindin liposomes with uniform particle size; 0.08 g of SGE-trehalose lyophilized powder was reconstituted with a small amount of PBS and then slowly added to the above-mentioned Mindin liposome suspension. The mixture was stirred at 4°C for 30 min (200 rpm) to allow the SGE protein to adsorb onto the surface of the liposomes or be partially encapsulated in the aqueous phase within the liposomes. Unencapsulated free protein was removed by ultrafiltration centrifugation (molecular weight cutoff 100 kDa, centrifugation force 4,000 × g, 4°C, 20 min), repeated 3 times.

[0034] Unencapsulated free Mindin protein was removed by ultrafiltration centrifugation (molecular weight cutoff 100 kDa, centrifugation force 4000 × g, temperature 4℃, time 20 min), repeated 3 times. The drug loading was determined to be 0.9% by the BCA method. S4. Weigh 21g of P407, 4g of P188, and 0.6g of HPMC, and slowly add them to 60 mL of pre-cooled purified water at 4℃. Let the solution swell at 4℃ for 18 hours, stirring every 6 hours (150 rpm for 5 minutes each time) until a clear, transparent solution is formed. Add purified water to a final volume of 100g, autoclave at 121℃ for 15 minutes, and cool to 4℃ for later use. The gelation temperature is 33±1℃; the gelation time at 37℃ is ≤45s.

[0035] Dissolve 2.5 g of DEET in 8 g of anhydrous ethanol and stir until completely dissolved (stirring speed 200 rpm, temperature 25℃, time 10 min). Add 2.5 g of walnut leaf essential oil and 1.2 g of Tween-80, and continue stirring for 20 min to obtain the active phase stock solution. At 4℃, slowly add the Mindin liposome suspension to the thermosensitive gel matrix and stir until homogeneous (stirring speed 300 rpm, time 15 min). Slowly add the active phase stock solution to the above mixture, add PBS buffer to a final volume of 100 g, and stir at 4℃ for 30 min (stirring speed 300 rpm). Aliquot into sealed, light-protected containers, purge with nitrogen, and store at 4℃.

[0036] Following the modified Franz diffusion cell method, using isolated porcine ear skin as the transdermal barrier, the effective diffusion area of ​​the diffusion cell was 1.77 cm². 2 The receiving tank has a volume of 7 ml; the receiving solution is PBS buffer (pH 7.4, containing 0.5% Tween-80), and a water bath circulation system (32±0.5℃). Isolated pig ear skin was fixed between the supply and receiving cells of a Franz diffusion cell, with the stratum corneum facing upwards. 0.5 g of samples from groups C0 (without Mindin protein), C1 (0.005% Mindin protein), C2 (0.01% Mindin protein), and C3 (0.02% Mindin protein) were added to the supply cell and evenly spread on the skin surface. PBS receiving solution was injected into the receiving cell and circulated in a water bath with magnetic stirring (300 rpm). Mindin protein content was determined using the BCA method, and the content of characteristic components of walnut leaf essential oil was determined by GS-MS. Cumulative permeation and steady-state transdermal rate were calculated. Results are shown in Table 1. Table 1 Permeability Experiment

[0037] The cumulative permeation of Mindin protein over 24 hours increased approximately linearly with increasing dosage, indicating that the transdermal permeation-enhancing effect of Mindin by the liposome-ionic liquid delivery system is dose-dependent. There was no significant difference in the permeation release of walnut leaf essential oil among the different dosage groups, suggesting that the addition of Mindin does not affect the transdermal behavior of the active ingredient, and that both components can independently perform their respective functions.

[0038] In vitro tick repellency test (Y-shaped olfactometer method) was conducted using a Y-shaped glass olfactometer (main tube diameter 2 cm, arm length 15 cm, included angle 75°) and *Tectus toranae* ticks. Rhipicephalus turanicus 40 adult ticks (half male and half female); qualitative filter paper (1 cm in diameter); put the 40 ticks into a transparent tube with the same diameter as the bottom of the Y-shaped tube, and seal it to the bottom of the Y-shaped tube.

[0039] 15 μL of each experimental group sample (C0, C1, C2, C3) was added to a 1 cm diameter circular filter paper at the left upper arm port of the Y-shaped tube, while the right upper arm port was left untreated. The ticks were attracted to climb upwards by placing both hands at the tube openings on both upper arms. The time it took for the first tick in each group to reach the upper arm port (repelling time) was recorded. Each group was repeated three times, and the average value was taken. The results are shown in Table 2. Table 2 Avoidance Experiment

[0040] The repellency time of all groups with added mindin was better than that of the group without mindin (71 min). The addition of mindin had a certain prolongation effect on the repellency time, which was dose-dependent. It is believed that this may be related to the fact that after the mindin liposomes formed a gel reservoir on the skin surface, they changed the release kinetics of the repellent active ingredients. The physical barrier effect of the liposome membrane and the gel matrix delayed the evaporation rate of the essential oil.

[0041] In vitro tick contact killing experiment (immersion method): Thirty starved adult *Fish-headed Tick* were used in 5 mL centrifuge tubes in a constant temperature incubator (27±1℃, RH≥80%). Ten starved adult ticks were placed in 5 mL centrifuge tubes. 1 mL of each experimental group sample (C0, C1, C2, C3) was injected to completely immerse the ticks in the sample. After immersion for 5 min, the ticks were removed and dried on filter paper. The ticks were then placed in clean test tubes and incubated in an incubator (27±1℃, RH≥80%) for 24 h. The number of dead ticks was counted, and each group was repeated three times. The results are shown in Table 3. Table 3. Contact Killing Experiment

[0042] The contact mortality rates of each addition group were basically the same, and the addition of Mindin had no significant effect on the contact killing effect (p>0.05), further confirming that Mindin and the active ingredient for killing are functionally independent and do not interfere with each other.

[0043] The antagonistic phase composed of walnut leaf essential oil and DEET is hydrophobic, while Mindin protein is a hydrophilic macromolecule. If the two are simply mixed, the hydrophobic small molecules easily lead to protein aggregation and inactivation. Liposomes, however, encapsulate Mindin within the inner aqueous phase, while simultaneously loading the antagonistic components into the liposome membrane and gel backbone. This avoids direct contact and conflict between the two, ensuring that the presence of high-concentration essential oil does not affect the structural integrity of Mindin. This solves the problem of incompatibility between hydrophilic and hydrophobic substances, providing the structural basis for the coexistence of chemical and immune barriers.

[0044] Walnut leaf essential oil or DEET alone evaporates rapidly on the skin surface, with repellent effects lasting only 36.33 minutes and 24.33 minutes, respectively. However, when combined, the repellent effect is prolonged. The principle behind this is that the liposome-gel complex matrix changes the evaporation pathway of the repellent ingredients from direct dispersion to a three-stage release mode: membrane distribution, gel blockage, and diffusion into the gas phase. When the small essential oil molecules break through the liposome membrane, they are dissolved and redistributed by the phospholipid bilayer, which greatly slows down their gas phase release rate, extending the duration of the repellent effect by more than 2.5 times.

[0045] Mindin protein has a molecular weight of approximately 30-40 kDa and cannot penetrate the stratum corneum when applied topically alone. Although the introduced ionic liquid can disrupt the lipid arrangement of the stratum corneum, the penetration efficiency of Mindin remains extremely low when used alone. When walnut leaf essential oil coexists with liposomes, the small terpenoid molecules in the essential oil have a chance to insert into the liposome bilayer, increasing membrane fluidity and the probability of transient pore formation. This makes it easier for the liposomes to fuse with the stratum corneum and release their contents on the skin surface, enabling Mindin, which was originally unable to be delivered transdermally, to achieve transdermal penetration for topical application.

[0046] DEET essential oil provides immediate chemical defense within 0 to 90 minutes after application, directly repelling and killing attached ticks and rapidly reducing the tick population load. Meanwhile, Mindin, successfully delivered to the epidermis, initiates pre-activation of the local immune microenvironment within this time window. As a pattern recognition molecule, Mindin does not act directly on ticks but pre-awakens Langerhans cells and dendritic cells in the skin, putting them in a state of alert. When a few ticks breach the chemical barrier, complete the bite, and inject pathogens, the pre-stimulated immune cells can quickly recognize and eliminate them. Traditional chemical agents only provide passive defense; once they fail, the host is exposed to pathogen risk. This combination upgrades the control mode from a single external blockade to a dual-insurance mechanism of external blockade + internal clearance through chemical killing and biological early warning, fundamentally overcoming the fundamental deficiency of simple tick-killing products in failing to enhance the host's active disease resistance.

[0047] Example 2: The above example achieved transdermal delivery by co-delivering Mindin with the expelling and killing ingredients. However, in practice, it was found that the encapsulation rate decreased to 29.6% during long-term storage. The reason for this is that the terpenoid molecules in walnut leaf essential oil continuously insert into the liposome bilayer, causing the burst release and inactivation of Mindin. Further improvements were made based on Example 1.

[0048] The difference from Example 1 is that this example sets the concentration of sodium chloride (NaCl) in the in vitro and in vivo aqueous phases of the liposomes in a hierarchical manner, with a higher concentration inside and a lower concentration outside: the in vivo aqueous phase is a hypertonic environment with a NaCl concentration of 0.85%~0.95% (osmotic pressure 280~320 mOsmol / L); the in vitro aqueous phase and gel matrix are hypotonic environments with a NaCl concentration of 0.15%~0.30% (osmotic pressure 50~100 mOsmol / L); the osmotic pressure difference between the in vitro and in vivo aqueous phases is strictly limited to 180~270 mOsmol / L.

[0049] In step S3, ultrasonic treatment is performed: ultrasonic power 150 W, total ultrasonic time 10 min (2 s per ultrasonic session, 3 s interval), with ice-water bath protection throughout, and temperature controlled at 4~10℃; the ultrasonicated liposome suspension is then extruded through a 0.45 μm polycarbonate membrane 5 times and a 0.22 μm polycarbonate membrane 5 times (extrusion pressure 1.0 MPa) to obtain Mindin liposomes with uniform particle size; 0.08 g of SGE-trehalose lyophilized powder was reconstituted with a small amount of PBS and then slowly added to the above-mentioned Mindin liposome suspension. The mixture was stirred at 4°C for 30 min (200 rpm) to allow the SGE protein to adsorb onto the surface of the liposomes or be partially encapsulated in the aqueous phase within the liposomes. Unencapsulated free protein was removed by ultrafiltration centrifugation (molecular weight cutoff 100 kDa, centrifugation force 4,000 × g, 4°C, 20 min), repeated 3 times.

[0050] Ultrafiltration centrifugation (molecular weight cutoff 100 kDa, centrifugation force 4000×g, temperature 4℃, time 20 min) was used, with hypotonic phosphate buffer (containing 0.15% NaCl, pH 7.4) as the replacement medium to replace the hypertonic to hypotonic aqueous phase of the lipid in vitro. This process was repeated 3 times. The drug loading was determined by the BCA method to be 0.9%. In the accelerated assay (25℃, 28 days), the encapsulation efficiency decreased from 72.4% to 29.6%, a drop of -42.8%. When using gradient osmotic pressure, the initial encapsulation efficiency was 71.5%, and after 28 days, it was still 66.1%. Furthermore, it decreased with increasing NaCl concentration. When the hypotonic phosphate buffer concentration increased to 0.3%, the initial encapsulation efficiency was 71.8%, and after 28 days it was 51.2%, a decrease of -20.6%. The osmotic pressure difference drives water molecules to continuously permeate from the hypotonic external phase to the hypertonic internal phase. When essential oil molecules insert into the liposome membrane to form transient pores, the inward water flow pushes the unbound Mindin protein back into the lumen, while simultaneously generating hydraulic pressure at the pore edges to inhibit pore size expansion. Ultimately, the larger the pores, the higher the water flow rate, and the stronger the blocking effect, forming a negative feedback regulatory loop that upgrades liposome stability from a passive barrier to an active regulatory system. This effectively solves the stability defect of sudden release and inactivation of immune adjuvants during shelf life caused by long-term attack by essential oil molecules, while extending the repellency time from 71.0 min to 84.3 min.

[0051] The above description is merely a preferred embodiment of the present invention and is not intended to limit the invention. For those skilled in the art, the present invention can have various modifications and variations. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.

Claims

1. A composition for repelling and killing ticks, characterized in that, It includes an immune-activating phase, a killer-active phase, and a thermosensitive in-situ gel matrix; The immune activation phase comprises liposomes loaded with recombinant Mindin protein and total protein from tick salivary gland extract, the liposomes being composed of phospholipids, cholesterol, polyethylene glycol-modified distearate phosphatidylethanolamine and a penetration enhancer; The repellent active phase contains plant essential oils and DEET; The thermosensitive in-situ gel matrix contains poloxamer and cellulose-based polymers; The immune-activating phase and the exterminating active phase are dispersed together in the thermosensitive in situ gel matrix, and the composition undergoes a phase transition under body temperature to form a semi-solid gel reservoir.

2. The tick-repelling composition according to claim 1, characterized in that, The composition comprises, by weight percentage: Mindin recombinant protein 0.005%-0.02%; The total protein content of tick salivary gland extract was 0.001%-0.01%. Trehalose 1%-3%; Phospholipids 2%-5%; Cholesterol content is 0.3%-1.0%, and the weight ratio of phospholipids to cholesterol is 4:1-10:1; 1,2-Propanediol 5%-10%; Penetration enhancer 0.5%-2.0%; Polyethylene glycol-modified distearate phosphatidylethanolamine 0.1%-0.5%; Plant essential oils 0.5%-5%; DEET 0.5%-5%; Anhydrous ethanol 5%-10%; Polysorbate-80 0.5%-2%; Poloxamer 407 18%-25%; Poloxamer 188 2%-6%; Hydroxypropyl methylcellulose 0.3%-1.0%; The remainder is phosphate buffer.

3. The tick-repelling composition according to claim 2, characterized in that, The penetration enhancer is choline-lauric acid or choline-oleic acid.

4. The tick-repelling composition according to claim 2, characterized in that, The plant essential oil is any one or a combination of clove essential oil, walnut leaf essential oil, and thyme essential oil.

5. The tick-repelling composition according to claim 1, characterized in that, The liposome has an inner aqueous phase and an outer aqueous phase. The sodium chloride concentration of the inner aqueous phase is 0.85%-0.95%, and the osmotic pressure is 280-320 mOsmol / L. The sodium chloride concentration of the outer aqueous phase and the thermosensitive in-situ gel matrix is ​​0.15%-0.30%, and the osmotic pressure is 50-100 mOsmol / L. The osmotic pressure difference between the inner and outer aqueous phases is 180-270 mOsmol / L.

6. The tick-repelling composition according to claim 1, characterized in that, The tick salivary gland extract was derived from the salivary glands of semi-saturated female adult ticks of the Turantopteris turanosa.

7. The tick-repelling composition according to claim 1, characterized in that, The temperature-sensitive in-situ gel matrix gels at 33℃±1℃, and the gelation time at 37℃ does not exceed 45 seconds.

8. A method for preparing the tick-repelling composition according to any one of claims 1-7, characterized in that, Includes the following steps: S1: The protein solution of tick salivary gland extract was mixed with trehalose and then freeze-dried to obtain tick salivary gland extract-trehalose freeze-dried powder; phospholipids, cholesterol and polyethylene glycol-modified distearate phosphatidylethanolamine were dissolved in an organic solvent, and the organic solvent was removed by rotary evaporation under reduced pressure to form a lipid membrane. S2: Dissolve the Mindin recombinant protein in phosphate buffer, add a penetration enhancer and 1,2-propanediol, and stir until completely dissolved to obtain a hydration solution; add the hydration solution to a container containing the lipid membrane and stir to hydrate and detach the lipid membrane completely to form a crude liposome suspension. S3: The crude liposome suspension is subjected to ultrasonic treatment and extrusion membrane to obtain liposomes; the tick salivary gland extract-trehalose lyophilized powder is reconstituted and added to the liposomes, so that the tick salivary gland extract protein is adsorbed on the surface of the liposomes or encapsulated in the aqueous phase of the liposomes; the unencapsulated free protein is removed by ultrafiltration centrifugation to obtain liposomes loaded with Mindin recombinant protein and total protein of tick salivary gland extract; S4: Poloxamer 407, poloxamer 188, and hydroxypropyl methylcellulose were added to pre-cooled purified water and swollen to obtain a thermosensitive in-situ gel matrix; DEET was dissolved in anhydrous ethanol, and plant essential oil and polysorbate-80 were added and stirred to obtain a repellent active phase stock solution; under low temperature conditions, the liposomes obtained in step S3 were added to the thermosensitive in-situ gel matrix and mixed, and then the repellent active phase stock solution was added, phosphate buffer was added, and the mixture was stirred and mixed to obtain the final product.

9. The preparation method according to claim 8, characterized in that, In step S3, the ultrafiltration centrifugation method uses an ultrafiltration membrane with a molecular weight cutoff of 100 kDa, a centrifugal force of 4000×g, a temperature of 4℃, and a time of 20 min, repeated 3 times; the freeze-drying conditions are: pre-freezing at -80℃ for 12 h, cold trap temperature of -50℃, vacuum degree less than 10 Pa, and freeze-drying time of 48 h; the ultrasonic treatment conditions are: ultrasonic power of 150 W, total ultrasonic time of 10 min, ultrasonic 2 s interval 3 s, ice-water bath protection throughout, and temperature controlled at 4-10℃; the extrusion membrane is extruded 5 times through a 0.45 μm polycarbonate membrane and 5 times through a 0.22 μm polycarbonate membrane, with an extrusion pressure of 1.0 MPa.

10. The preparation method according to claim 8, characterized in that, In step S3, a hypotonic phosphate buffer is used as the replacement fluid for ultrafiltration centrifugation to replace the lipid in vitro aqueous phase with a hypotonic environment. The hypotonic phosphate buffer has a sodium chloride concentration of 0.15%-0.30% and a pH of 7.4.